 Pharmeceutical Intermediates |
| Malonic acid |
Assay≥99.5% |
CAS:141-82-2 |
| Malonamide |
Assay≥99% |
CAS:108-13-4 |
2,4-Diamino-6-chloropyrimidine |
Assay≥99% |
CAS:156-83-2 |
2,4,6-Triaminopyrimidine |
Assay≥98% |
CAS:1004-38-2 |
2,4,5,6-Tetraminopyrimidine sulfate |
Assay≥99% |
CAS:5329-28-9 |
| 2-Chloropyrimidine |
Assay≥99% |
CAS:1722-12-9 |
| 2-Cyanopyrimidine |
Assay≥99% |
CAS:14080-23-0 |
| N,N-Dimethylformamide dimethyl acetal |
Assay≥98% |
CAS:4637-24-5 |
| (S)-(-)-2-Chloropropionic acid |
Assay≥98% |
CAS:29617-66-1 |
| 2-(2-Chloroethoxy)ethanol |
Assay≥99% |
CAS:628-89-7 |
| 1-Hydroxyethoxyethylpiperazine |
Assay≥99% |
CAS:13349-82-1 |
| 3-Amino-2-chloro-4-methyl pyridine |
Assay≥99% |
CAS:133627-45-9 |
| 2-Cyano-3-methylpyridine |
Assay≥99% |
CAS:20970-75-6 |
| 2,3-Dimethyl-4-Nitropyridine N-Oxide |
Assay≥99% |
CAS:37699-43-7 |
| 2,3-Dimethyl-4-chloropyridine-N-oxide |
Assay≥98.5% |
CAS:59886-90-7 |
| 6-Chloropurine-9-(2,3-isopropylidene)-b-d-ribfuraniside |
Assay≥98% |
CAS:39824-26-5 |
| 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine hydrochloride(Rabeprazole intermediate ) |
Assay≥98% |
CAS:153259-31-5 |
| 9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-amino-6-chloropurine |
Assay≥97% |
CAS:97845-60-8 |
| Diethyl aminomalonate |
Assay≥99% |
CAS:6829-40-9 |
| Methyl 4,4-dimethoxy acetylacetate |
Assay≥99% |
CAS:60705-25-1 |
| 2,3-Pyridinedicarboxylic acid |
Assay≥99% |
CAS:89-00-9 |
| 3,4'-oxydianiline |
Assay≥99% |
CAS:2657-87-6 |
| 2-(1-Piperazinyl)pyrimidine dihydrochloride |
Assay≥98% |
CAS:20980-22-7 |
(R)-3-Amino-3-phenylpropionicacid hydrochloride |
Assay≥98% |
CAS:83649-48-3 |
| 2-Hydroxynicotinic acid |
Assay>99% |
CAS:609-71-2 |
| 2-Chloroisonicotinic acid |
Assay>97% |
CAS:6313-54-8 |
| 2,6-Dichloronicotinic acid |
Assay>99% |
CAS:38496-18-3 |
| 5-bromo-3-pyridine carboxlic acid |
Assay>99% |
CAS:20826-04-4 |
| 6-hydroxynicotinic acid |
Assay>99% |
CAS:5006-66-6 |
| 6-Methyl-nicotinic acid methyl ester |
Assay>99%(HPLC) |
CAS:5470-70-2 |
| 2-Chloronicotinoyl chloride |
Assay>99% |
CAS:49609-84-9 |
| 6-Chloropurine-9-(2,3-isopropylidene-b-D-ribofuranoside) |
Assay>98% |
CAS:39824-26-5 |
| 5-Hydroxynicotinic acid |
Assay≥98% |
CAS:27828-71-3 |
| N2-Phenylacetyl guanosine |
Assay≥99%
|
|
| N4-benzoyl adenosine |
Assay≥99%
|
|
| N6-benzoyl cytosine |
Assay≥99%
|
|
| 6-chloro-3-pyridinecarboxylic acid |
Assay>99% |
CAS:5326-23-8 |
| 2-Aminonicotinic acid |
Assay>98% |
CAS:5345-47-1 |
| Butyl ( R )-(+)-2-(4-Hydroxyphenoxy)-propanoate |
Assay≥98%
|
|
| Ethyl ( R )-(+)-2-(4-Hydroxyphenoxy)-propanoate |
Assay≥98%
|
|
| Methyl( R )-(+)-2-(4-Hydroxyphenoxy)-propanoate |
Assay≥98% |
CAS:96562-58-2 |
| (R)-(+)-2-chloropropionic acid |
Assay≥98% |
CAS:7474-05-7 |
| (R)-(+)-2-(4-hydroxyphenoxy)propionic acid |
Assay≥98% |
CAS:94050-90-5 |
| 2-Deoxy-2-fluoro-1,3,5-tribenzoate-alpha-D-arabinofuranose |
Assay≥98%
|
CAS:97614-43-2 |
| Bulk Pharmaceuticals
|
| Valaciclovir hydrochloride |
Assay≥98-102% |
CAS:124832-27-5 |
| Famciclovir |
Assay≥98.5% |
CAS:104227-87-4 |
| Zaleplon |
Assay≥99% |
CAS:151319-34-5 |
N-Ethyl-N-3-[(3-dimethylamine-1-oxo-2-propene)phenyl]acetamide(intermediate of Zaleplon) |
Assay≥99% |
CAS:96605-66-2 |
3-Amino-4-cyanopyrazole(intermediate of Zaleplon) |
Assay≥98.5% |
CAS:16617-46-2 |
Sumatriptan |
Assay≥99% |
CAS:103628-48-4 |
| Nevirapine |
Assay≥99% |
CAS:129618-40-2 |
| Efavirenz |
Assay≥99% |
CAS:154598-52-4 |
| Quetiapine fumarate |
Assay≥99% |
CAS:111974-72-2 |
| L-alanyl-LgLutamine |
Assay≥99%
|
CAS:39537-23-0 |
